Jul. 21 at 3:35 PM
Everything you need to know about the
$6.5M Amylyx Pharmaceuticals (
$AMLX) Settlement:
Q: What happened?
A: Amylyx Pharmaceuticals was accused of misleading investors about the launch of Relyvrio, including demand, discontinuations, and the drug’s commercial growth prospects. Investors claim the company presented a stronger growth outlook than reality supported. After Amylyx disclosed slowing patient growth and higher discontinuations,
$AMLX fell 31.89% and investors filed a lawsuit.
Q: Am I actually eligible?
A: If you bought
$AMLX shares between 2022 and 2023, you’re likely eligible.
Q: When do payouts happen?
A: Typically, within 4–9 months after the claim deadline. The exact timing depends on the court and settlement administration.
Check if you're eligible and submit your claim: https://11th.com/cases/amylyx-pharmaceutical-investor-settlement
